Shopping Cart
- Remove All
- Your shopping cart is currently empty
A17, a bile acid analog, exhibits anti-non-alcoholic steatohepatitis (NASH) and anti-inflammatory properties. This compound diminishes fatty acid (FA) uptake and enhances FA oxidation by suppressing fatty acid translocase (Cd36) expression and stimulating AMPKα activity. A17 is applicable in NASH research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | A17, a bile acid analog, exhibits anti-non-alcoholic steatohepatitis (NASH) and anti-inflammatory properties. This compound diminishes fatty acid (FA) uptake and enhances FA oxidation by suppressing fatty acid translocase (Cd36) expression and stimulating AMPKα activity. A17 is applicable in NASH research. |
Molecular Weight | 533.74 |
Formula | C31H51NO6 |
Cas No. | 2568186-47-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.